Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.77
-0.03 (-0.34%)
Aug 26, 2026, 1:03 PM EDT - Market open
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $696.6 million as of August 26, 2026. Its market cap has decreased by -15.13% in one year.
Market Cap
696.60M
Enterprise Value
1.07B
1-Year Change
-15.13%
Ranking
Category
Stock Price
$8.77
ChartMarket Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $696.60M, an increase of 32.15%. That is a compound annual growth rate of 4.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 696.60M | -40.98% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 727.78M |
| Assembly Biosciences | 719.44M |
| Gyre Therapeutics | 712.64M |
| Tectonic Therapeutic | 712.48M |
| AgomAb Therapeutics NV | 708.68M |
| Allogene Therapeutics | 708.26M |
| Zevra Therapeutics | 698.95M |
| OmniAb | 689.15M |